DelistingJun 12, 2026, 04:37 PM
Wellgistics Health Gets Nasdaq Extension for Equity Rule
AI Summary
Wellgistics Health, Inc. received an extension from Nasdaq until October 12, 2026, to regain compliance with the $2.5 million stockholders' equity requirement, which was $(12,447,801) as of December 31, 2025. The company is pursuing a merger with DataVault AI and other acquisitions, projecting a post-transaction stockholders' equity of approximately $40 million and a combined asset value of $4 billion. Separately, Nasdaq confirmed that Wellgistics Health has regained compliance with the minimum $1.00 bid price requirement, closing that matter.
Key Highlights
- Nasdaq granted Wellgistics Health an extension until October 12, 2026, to regain compliance with the stockholders' equity requirement.
- Wellgistics Health's stockholders' equity was $(12,447,801) as of December 31, 2025, below the $2,500,000 Nasdaq minimum.
- The company plans a merger with DataVault AI and acquisitions, projecting post-transaction stockholders' equity of approximately $40 million.
- Wellgistics Health estimates a potential combined asset value of $4 billion post-transaction.
- Nasdaq confirmed Wellgistics Health regained compliance with the $1.00 minimum bid price requirement as of June 9, 2026.
- The company's common stock closing bid price was $1.00 or greater from May 26, 2026, to June 8, 2026.
Price Impact
More from WGRX